Methylation and de-methylation of histone lysine residues play pivotal roles in mammalian early development; these modifications influence chromatin architecture and regulate gene transcription. Fbxl11 (F-box and leucine-rich repeat 11)/Kdm2a is a histone demethylase that selectively removes mono-and di-methylation from histone H3K36. Previously, two other histone H3K36 demethylases (Jmjd5 or Fbxl10) were analyzed based on the phenotypes of the corresponding knockout (KO) mice; the results of those studies implicated H3K36 demethylases in cell proliferation, apoptosis, and senescence (Fukuda et al., 2011; Ishimura et al., 2012) . To elucidate the physiological role of Fbxl11, we generated and examined Fbxl11 KO mice. Fbxl11 was expressed throughout the body during embryogenesis, and the Fbxl11 KO mice exhibited embryonic lethality at E10.5-12.5, accompanied with severe growth defects leading to reduced body size. Furthermore, knockout of Fbxl11 decreased cell proliferation and increased apoptosis. The lack of Fbxl11 resulted in downregulation of the Polycomb group protein (PcG) Ezh2, PcG mediated H2A ubiquitination and upregulation of the cyclindependent kinase inhibitor p21
Introduction
Epigenetic regulation mediated by histone modifications is crucial for mammalian embryonic development. Histones undergo several types of post-translational modifications, including methylation, acetylation, phosphorylation, ubiquitilation, and SUMOylation, all of which can influence regulation of target gene expression. In particular, the methylation status of specific lysine residues on histone H3 is involved in the regulation of numerous genes, including some that are essential for development and differentiation. For instance, methylation on H3K4 and H3K36 is closely associated with transcriptional activation, whereas methylation on H3K9 and H3K27 correlates with gene silencing. Dysregulation of histone de-methylation (e.g., by mutation or overexpression of methylation factors) leads to developmental abnormalities, cancer, and neurological disorders. Taken together, these observations indicate that histone de-methylation is essential for development and homeostasis (Klose and Zhang, 2007; Shi, 2007) .
Fbxl11 (F-box and leucine-rich repeat protein 11, also called Kdm2a or Jhdm1a) was first identified as a histone demethylase containing a JmjC domain (Tsukada et al., 2006) . Fbxl11 is closely related to another protein, Fbxl10/Kdm2b (Pfau et al., 2008) . Fbxl11 and Fbxl10, which have similar structures, contain several functional domains: an F-box domain (protein binding), a CXXCzinc finger domain (DNA binding), a PHD domain, three leucinerich repeats, and a Jumonji domain (associated with histone demethylase activity). Fbxl11/Fbxl10 both have histone demethylase activity toward mono-and di-methylated histone H3 on lysine 36.
Several reports show that Fbxl10 and Fbxl11 play critical roles in cell proliferation, apoptosis, differentiation, senescence, and tumorigenesis by exerting their H3K36 demethylase activities at target genomic loci. Fbxl11 regulates differentiation and proliferation of mesenchymal stem cells (MSCs) by demethylating genes encoding cell-cycle regulators, including p15
Ink4b and p27 Kip1 Du et al., 2013; Gao et al., 2013) . Fbxl10 regulates cell growth and senescence by repressing p19 ARF , p15
Ink4b
, and p16 Ink4a in mouse embryonic fibroblasts (MEFs) (Fukuda et al., 2011; He et al., 2008; Kottakis et al., 2011; Pfau et al., 2008; Tzatsos et al., 2009 ). Moreover, both Fbxl11 and Fbxl10 negatively regulate cell growth by repressing ribosomal RNA transcription (Frescas et al., 2007; Tanaka et al., 2010) . Both proteins have also been implicated in cancer: Fbxl11 promotes lung tumorigenesis, and Fbxl10 is overexpressed in human pancreatic cancer (Dhar et al., 2014; Tzatsos et al., 2013; Wagner et al., 2013) . Thus, Fbxl10 and Fbxl11 have similar functions, and they target similar sets of genes in multiple cellular contexts. However, their physiological roles in vivo remain unclear. Previously, we generated Fbxl10 knockout (KO) mice. Those mutants exhibited an abnormal increase in both cell proliferation and apoptosis, resulting in neural tube defects and exencephaly. Therefore, we proposed that Fbxl10 is important for cell proliferation during early neurogenesis (Fukuda et al., 2011) . However, because no more than 20% of Fbxl10 KO mice exhibited exencephaly, we hypothesized that the low penetrance of this phenotype in Fbxl10 KO mice depends on functional redundancy and compensation between Fbxl10 and Fbxl11.
To investigate the physiological roles of Fbxl11 during early development, we generated both Fbxl11 reporter and Fbxl11 KO mice. Using these mice, we observed that Fbxl11 is widely and ubiquitously expressed during embryogenesis, and that Fbxl11 deficiency leads to severe growth retardation with embryonic lethality at the midgestation stage. Furthermore, p21
Cip1
was up-regulated in Fbxl11 KO mice. Together, these data suggest that the histone demethylase Fbxl11 plays an essential role in cell proliferation by downregulating expression of p21
, and that like Fbxl10, Fbxl11 regulates cell proliferation during early development.
Results

2.1.
Fbxl11 KO mice exhibited growth retardation and embryonic lethality
To investigate the physiological role of Fbxl11 during early development, we generated a mutant allele of Fbxl11 by gene targeting in embryonic stem (ES) cells, and introduced these cells into the mouse germline. The Fbxl11 targeting strategy is shown in Fig. 1A . The Fbxl11 targeting vector, obtained from the KOMP, contains a lacZ-neo cassette flanked by FRT sites and targeting exons flanked by loxP sites. The lacZ cassette was used for reporter analysis (i.e., to visualize expression), and the neo cassette was used for positive selection of neomycinresistant ES cell clones. Exons 7-9, which were targeted by this construct, encode the JmjC domain, which has histone demethylase activity (Tsukada et al., 2006 are depicted in Fig. 1D . At E10.5, Fbxl11 −/− embryos were present at the predicted (i.e., Mendelian) proportions, and their heartbeats were normal. However, Fbxl11 −/− mice at E10.5 exhibited severe growth retardation (Fig. 1D) . Furthermore, some of them were shown incomplete embryonic turning, and neural tube closure defects (data not shown). To determine whether the morphological abnormalities in Fbxl11 −/− mice were represented at stages earlier than E10.5, we dissected Fbxl11
intercrosses at E8.5 and E9.5. There were no phenotypic difference between control and Fbxl11 −/− embryos at E8.5, but
Fbxl11
−/− embryos at E9.5 were considerably smaller than control embryos. Because no further growth occurred from E8.5 to E10.5, the Fbxl11 −/− embryos at E10.5 were the same size as wild-type embryos at E8.5. These observations suggested that the growth retardation in Fbxl11 −/− embryos began at E8.5, resulting in embryonic lethality starting on or around E10.5. We concluded that Fbxl11 is required for proper development at embryonic stages, including cell proliferation in various organs.
Fbxl11 expression during embryogenesis
To obtain additional information about the role of Fbxl11 in development, we analyzed the patterns of Fbxl11 (Fig. 2B ). The lacZ reporter gene knocked into the Fbxl11 locus was expressed at low levels at E8.5, but throughout the whole body at E10.5-E14.5. Notably, Fbxl11 expression was most prominent in the forebrain and limbs at E12.5 and E14.5. Next, we performed real-time PCR and Western-blot analyses, using extracts of whole embryos, to quantitate the endogenous expression levels of Fbxl11 mRNA and protein at E8.5-E12.5. The Fbxl11 mRNA level was significantly elevated at the stage at which knockouts exhibited embryonic lethality (E10.5-E12.5), whereas the Fbxl10 mRNA level was slightly elevated at an earlier time (E8.5-E10.5) (Fig. 2C ). These results suggested that the increase in expression of Fbxl11 at E10.5-E12.5 might be related to the timing of embryonic lethality in Fbxl11 −/− embryos. Our data regarding the Fbxl11 expression profile during embryogenesis were supported by our previous study, in which we used Northern-blot analysis to show that Fbxl11 mRNA is ubiquitously expressed during embryogenesis and in several adult tissues (Fukuda et al., 2011) .
Loss of cell proliferation and elevation of apoptosis in
To elucidate the details of the severe developmental retardation observed in Fbxl11 −/− embryos, we performed histological analyses of horizontal sections of Fbxl11-mutated embryos. Hematoxylin-eosin staining of embryos at E10.5 revealed that Fbxl11 −/− mice contained fewer neuroepithelial cells, but had normal brain structures ( Fig. 3A and B). Additionally, Fbxl11
embryos had smaller hearts with cardiac looping defects ( Fig. 3C and D). Thus, Fbxl11 −/− embryos exhibited delayed organogenesis, but formed normal structures of major organs, including the central nervous system and heart. We reported previously that neural progenitor cell death is elevated in Fbxl10 KO mice. Therefore, we analyzed the role of Fbxl11 in neural development. We performed immunohistochemistry for the horizontal section of Fbxl11 +/− and Fbxl11 −/− embryos at E10.5 using specific antibodies for the neural stemcell marker Nestin, the differentiated neuron marker Tuj1, and the neural cell adhesion marker N-cadherin. The expression pattern of Nestin and N-cadherin was similar in Fbxl11 +/− and Fbxl11 −/− embryos. However, the differentiated neuron marker Tuj1 was not detected in the forebrain of Fbxl11 −/− embryos, although it was still expressed in the hindbrain (Fig. 3B) , indicating that neural differentiation in the forebrain was mostly arrested in Fbxl11 −/− embryos. Because the hindbrain develops earlier than the forebrain, these findings suggested that Fbxl11 regulates the timing of appropriate neuronal differentiation. Next, to examine cell proliferation and apoptosis in the brain, we detected phospho-histone H3 (PH3) and cleaved caspase3 (CC3) by immunohistochemistry in the same sections. PH3 expression in mitotic cells of the ventricular zone was significantly reduced, whereas the proportion of CC3-positive apoptotic cells was dramatically elevated in Fbxl11 −/− neocortex ( Fig. 4A and   B ). Notably, as reported previously for Fbxl10 KO embryos, apoptosis in the neural crest was elevated in Fbxl11 −/− embryos (data not shown). We concluded that the proliferation defects and elevated apoptosis were responsible for the growth retardation observed in Fbxl11 −/− embryos.
Fbxl11 regulates expression of cell-cycle regulators
A recent study showed that Fbxl11 inhibits the expression of p15
Ink4b and p27 Kip1 by demethylating histone H3K4 at these loci, resulting in regulation of cell proliferation in MSCs (Gao et al., 2013) . In addition, we reported that Fbxl10 regulates cell growth by repressing p19 Arf in E8.5 embryos (Fukuda et al., 2011 , and p19
Arf were expressed at levels below the limit of detection in the embryos at E8.5 (data not shown). These data suggested that Fbxl11 regulates cell proliferation by repressing p21 Cip1 during the embryonic period, and that Fbxl11 might play a different role in cell-cycle regulation than that specified in previous studies. p53, a tumor suppressor, plays a key role in both cell proliferation and apoptosis. Because p53 activates the transcription of p21 Cip1 (Wood and Shilatifard, 2006) , we measured the p53 transcriptional level by real-time PCR to determine Immunohistochemistry using α-Nestin, α-Tuj1 and α-N cadherin antibodies on similary section. DAPI was used to counterstain cell nuclei. Bar =100 µm.
whether deletion of Fbxl11 also affected on the p53 transcriptional expression. The results showed that p53 transcriptional level was not elevated in Fbxl11 −/− embryos, also the expression of p53 protein was not detected, most likely due to the low abundance ( Fig. 5 and Supplemental Fig. S1 ). Therefore, Fbxl11 regulates p21
Cip1
, without activating p53 transcription, and this regulation is important for proper control of embryonic proliferation.
Fbxl11 influences the level of Polycomb-mediated histone modification
Histone H3K36 and H3K4 methylation are marks of active gene expression (Noma et al., 2001; Wagner and Carpenter, 2012) . Fbxl11 catalyzes H3K36me1/me2 and H3K4me3 demethylation, resulting in gene silencing (Bartke et al., 2010; Tsukada et al., 2006) . We measured Fbxl11-associated histone modification levels by Western blotting, as reported previously, using histone H3 expression as an internal control. Unexpectedly, there were no global changes in the levels of H3K36 mono-, di-, and tri-methylation, or H3K4 tri-methylation between control and Fbxl11 −/− whole embryos at E10.5 (Fig. 6A ).
These findings suggest that Fbxl11-associated H3K36 methylation is not distributed throughout the whole genome. The Fbxl11 homolog, Fbxl10 regulates gene expression by interacting with Polycomb group proteins (PcGs) (Farcas et al., 2012; Kottakis et al., 2011; Tzatsos et al., 2011; Wu et al., 2013) . PcGs, which are components of protein complexes involved in gene silencing, have been implicated in various phenomena related to tissue homeostasis, including stem-cell differentiation, tumorigenesis, and senescence. These earlier studies led us to speculate that Fbxl11 associates with PcG genes. Fbxl10 knockdown reduced the level of histone H2A ubiquitination without altering the expression of the PcG core components Ezh2 and Ring1B in mouse ES cells (Farcas et al., 2012; Wu et al., 2013) . Fbxl11 depletion also reduced the level of ubiquitinated H2A (Fig. 6A) Ezh2 and Ring1B transcript levels at E10.5 were lower in Fbxl11 −/− embryos than control embryos (Fig. 6C) . We also exhibited that Fbxl11 −/− embryos at E10.5 showed severe growth retardation and massive cell death (Fig 1D) . Hence, there is a possibility that newly synthesized mRNA were reduced, or the degradation rates of almost all RNA were enhanced in Fbxl11 null embryos at E10.5. Therefore, We interpreted that the Ring1B protein of almost same amount in Fbxl11 null and control embryo (represented in Fig. 6 ) might be due to remained Ring1B protein translated before E10.5. However, the Ezh2 protein expression is dramatically decreased in null embryo. These results suggested that Fbxl11 regulate with PcG component Ezh2 expression, and PcG mediated H2A ubiquitination.
Discussion
In this study, we generated KO mice lacking Fbxl11, a Jumonji C (JmjC)-domain-containing histone demethylase. The main findings are the demonstration that Fbxl11 KO mice exhibited embryonic lethality at E10.5-12.5, accompanied with severe growth retardation. Deletion of Fbxl11 in vivo inhibited cell proliferation and promoted cell death ( Fig. 4A and B) , and upregulated the cell-cycle inhibitor p21 Cip1 (Fig. 5 ). Fbxl11 depletion also led to a major loss of H2A ubiquitination (Fig. 6A) . Thus, we showed for the first time that Fbxl11 plays a critical role in homeostasis by regulating cell proliferation and survival during embryogenesis. Recently, over 30 proteins have been identified as JmjCdomain-containing histone demethylases (Kooistra and Helin, 2012; Mosammaparast and Shi, 2010; Pedersen and Helin, 2010) . So far, the physiological roles of these proteins have been investigated by generation and examination of KO mice. The in vivo phenotypes, resulting from targeted disruption of JmjCdomain-containing histone demethylases, vary in severity from mild to fatal. For example, deficiency of either Utx (also known as Kdm6a) or Jarid2 causes embryonic lethality (Baker et al., 1997; Cox et al., 2010; Lee et al., 2012) . By contrast, deletion of Kdm4d (also known as Jmjd2d /Jhdm3d) or Kdm3a (also known as Jmjd1a/Jhdm2a) results in viable animals with either no detectable phenotype or a very modest (Inagaki et al., 2009; Iwamori et al., 2011; Okada et al., 2007) .
Fbxl10 (Kdm2b), a paralog of Fbxl11 with 80% sequence identity to Fbxl11 within the JmjC domain, specifically targets monoand di-methylated H3K36. Fbxl10 KO mice cannot undergo neural tube closure, leading to neonatal death. In addition, the cell-cycle inhibitor p19 ARF is up-regulated in Fbxl10-deleted MEFs;
Fbxl10 contributes to regulation of cell proliferation and apoptosis during the embryonic period (Fukuda et al., 2011) . Based on their homology, we predicted functional overlap between Fbxl10 and Fbxl11 during embryogenesis. However, the phenotype of Fbxl11 null mice is much more severe than that of Fbxl10 KO mice. The distinct in vivo KO phenotypes of Fbxl10 and Fbxl11 may be due to differences in spatiotemporal control of gene expression. Fbxl10 expresses in specific organs, such as the brain and testis during early embryogenesis. By contrast, our experiments using Fbxl11 reporter mice indicated that Fbxl11 expression occurs throughout the whole body, predominating in the cerebral cortex and limbs in the fetus (Fig. 2B) . The expression peak of Fbxl11 during embryogenesis is later than that of Fbxl10 (Fig. 2C) . These results suggest that during early development, Fbxl11 plays a role distinct from that of Fbxl10.
On the other hand, several Fbxl11-null mice exhibited neural tube closure defects and elevated neural-crest cell apoptosis, similar to Fbxl10 KO mice (data not shown). Moreover, expression of neural differentiation markers was reduced in Fbxl11-null embryos (Fig. 3B ). Therefore, it is possible that Fbxl10 and Fbxl11 exert partially overlapping functions during neural development. But we could not observe Fbxl11 KO phenotypes during later neurogenesis, because of the embryonic lethality. Currently, we are generating neural-lineage-specific Fbxl11/ Fbxl10 double-KO mice to investigate the functional correlation between Fbxl11 and Fbxl10 during early development of the central nervous system.
The phenotypes of Fbxl11 KO mice were similar to those of Jmjd5-deficient mice. Like Fbxl11, Jmjd5 has a Jumonji domain with the ability to demethylate di-methylated lysine 36 of histone H3 (Hsia et al., 2010) . Interestingly, Jmjd5 KO mice exhibit embryonic lethality at E10.5 (Ishimura et al., 2012; Oh and Janknecht, 2012) and upregulation of the cell-cycle inhibitor p21
Cip1 . Deletion of Fbxl11 and Jmjd5, which remove methyl groups from histone H3K36, induce similar developmental abnormalities. The biological function of methylation of histone H3K36 is not fully understood, although it is known that H3K36 methylation is distributed on active chromatin, and this modification has been implicated in transcriptional regulation, DNA replication, homologous recombination, and DNA doublestrand break repair (Wagner and Carpenter, 2012) . Our data and previous findings led us to postulate that cell-cycle regulation by H3K36 methylation is essential for mouse early development. We revealed that p21 Cip1 was significantly up-regulated in Fbxl11-null embryos (Fig. 5) . p21 Cip1 is a transcriptional target of p53 in the presence of DNA damage (Takimoto and El-Deiry, 2001) , and p21 Cip1 expression results in cell-cycle arrest and apoptosis, which maintain cell homeostasis. Recent work has shown that a few epigenetic factors control p21 Cip1 transcription independently on p53 (Gartel and Radhakrishnan, 2005; Wood and Shilatifard, 2006) . HDAC1-and Jmjd5-deficient mice exhibit upregulation of p21
Cip1
and embryonic lethality with severe growth delay during midgestation, as in the case of Fbxl11 (Ishimura et al., 2012; Lagger et al., 2002 ). We showed p53 mRNA level was not change between Fbxl11 null and control embryos, and p53 protein expression was hardly detected in mouse whole embryo lysate ( Supplementary Fig. S1 ). In the current study, Ishimura et al. indicated that Jmjd5 directly represses p21 Cip1 by demethylating H3K36, as demonstrated using MEFs derived from Jmjd5-KO mice. On the other hand, Oh et al. concluded that Jmjd5 affect both of the transcriptional expressions of p53 and its downstream genes (p21 Cip1 and Noxa) in Jmjd5-KO embryos. These conflicting findings may be explained by depending on cell contexts and differences in developmental timing. Thus, it remains the possibility that Fbxl11 suppress p21 Cip1 expression, directly via histone modification at this locus, or indirectly via p53 activation with post-translational modifications. Regardless of p53 regulation, we concluded that p21 Cip1 upregulation in Fbxl11-null embryos is one of the main causes of abnormalities related to cell growth and apoptosis. We interpreted this to mean that the main cause of embryonic lethality in Fbxl11 knockouts was the reduction in cell viability resulting from slower proliferation and higher rates of apoptosis. However, other factors may be involved in embryonic death in Fbxl11-null embryos. We are currently exploring the changes in gene-expression profiles and interactions of epigenetic factors associated with Fbxl11 deletion, using DNA microarrays and chromatin immunoprecipitation with massively parallel DNA sequencing (ChIP-seq), respectively.
The histone methylation level was not changed in Fbxl11-null mice (Fig. 6A) . This finding led us to speculate that Fbxl11 is not the major histone H3K36 demethylase during early development. Alternatively, it may not be possible to detect the distribution of histone modifications by Fbxl11 on target loci by Western blotting performed on bulk protein lysate. To investigate this matter in greater depth, ChIP analysis is an appropriate method. We could not produce MEFs derived from Fbxl11-KO mice for use in ChIP assays, because Fbxl11-null
) exhibited embryonic lethality at E10.5-E12.5 (Tables 1 and 2) , which is the most suitable stage for producing MEFs. In the future, we plan to perform ChIP assays using shRNAs targeting Fbxl11, or Fbxl11-KO ES cells, and to use these systems to elucidate the detailed molecular mechanism of target gene regulation by Fbxl11. PcGs form two complexes, Polycomb repressive complexes (PRC) 1 and 2. Fbxl10 has been known as a new component and recruiter of PRC1 (Cooper et al., 2014; Farcas et al., 2012; Wu et al., 2013) . Recruitment of canonical PRC1 is dependent on tri-methylated H3K27 deposited by PRC2. By contrast, Fbxl10 binds to non-methylated CpG islands and recruits PRC1 to target locus in the absence of a PRC2-mediated H3K27me3 modification mark. Moreover, Fbxl10-PRC1 (novel PRC1) recruits PRC2, which is involved in the distribution of H3K27me3 on target gene loci (Blackledge et al., 2014) . Recently, a great deal of attention has been paid to the role of Fbxl10 as a novel key regulator of non-canonical PRC1 in ES cells. Although Fbxl11 is also distributed on CpG islands throughout the genome, Fbxl11 does not bind to PRC1 components in mouse ES cells (Wu et al., 2013) . To investigate whether Fbxl11 associates with PcGs in vivo, we measured H2A ubiquitination levels in Fbxl11-null embryos. Surprisingly, the results showed that Fbxl11 associates PRC1-mediated histone modification in vivo (Fig. 6C) . Moreover, Fbxl11 deletion led to a reduction in Ezh2 mRNA and protein (Fig. 6C) . A similar effect was not observed with Fbxl10, knockout of which did not affect PcG gene-expression levels in ES cells (Farcas et al., 2012; Wu et al., 2013) . On the other hand, another group reported that Fbxl10 knockdown leads to downregulation of Ezh2 mRNA by regulating miRNAs in MEFs (Tzatsos et al., 2011) . Thus, Fbxl10 indirectly up-regulates Ezh2 mRNA by influencing miRNA levels, promoting cell proliferation and inhibiting cellular senescence in certain contexts. We suggest that Fbxl11 may functionally overlap, at least in part, with PcG and Fbxl10 in the midgestation embryos; however, further study will be required to confirm this.
Finally, it was reported that Fbxl10 has two isoforms; the full-length isoform has the JmjC domain, CXXC zinc-finger, PHD zinc-finger, F-box and leucine-rich repeat, while the short isoform lacking the N-terminal JmjC domain (Pfau et al., 2008) . The CXXC zinc-finger domain, commonly present in both Fbxl10 isoforms, was necessary for recruitment of PRC1 to target locus. Disruption of the CXXC zinc-finger domain in mice led to embryonic lethality (Blackledge et al., 2014) . Their phenotypes were much more severe than the Fbxl10 KO mice, we reported previously, because our targeting strategy of Fbxl10 gene was designed in which exon that encodes the JmjC domain (Fukuda et al., 2011) . From these reports, each isoform of Fbxl10 has the biological different functions. It will need consideration that Fbxl11 may have multi-functions mediated by several domains, as well as Fbxl10.
Experimental procedures
ES cells culture
JM8 ES cells derived from C57BL6/J mice were cultured in Knockout DMEM (Gibco) supplemented with 1% Glutamax (Gibco), 20% fetal bovine serum, 100 nM 2-mercaptoethanol, LIF, 3 µM CHIR99021 (Biovision), and 1 µM PD0325901 (Axon).
Generation of Fbxl11 mutant mice
The Fbxl11 targeting vector (clone name: PG00184_Z_8_C04) was purchased from KOMP (Knockout Mouse Project). The linearized targeting vector was electroporated into JM8 ES cells, which were then screened for homologous recombination by PCR. For genotyping PCR, the following oligonucleotide primers were used: 
Embryo collection
Fbxl11 +/neo and Fbxl11 +/null mice were intercrossed, and male
Fbxl11
+/lacZ reporter mice were mated with female C57/BL6J mice.
Pregnant mice with plugs observed at noon were considered to be at E0.5. Embryos (E8.5-E18.5) were dissected and their genotypes determined by PCR using the amnion and tail genomic DNA as templates. The following primers were used for genotyping PCR:
null allele Forward① 5′-CATCTTCAGCCCTGATCTTTGT-3′ neo allele Forward② 5′-CACAACCTGGAGCTGTACGA-3′ Reverse③ 5′-ACATTTGAGAAGCACTGTACCA-3′ (the reverse primer is common for "null allele" and "neo allele") lacZ allele lacZ F 5′-CACACCTCCCCCTGAACCTGAAAC-3′ lacZ R 5′-GTCTGAGCTCGCCATCAGT-3′
X-gal staining
Collected embryos were fixed with 1% paraformaldehyde and 0.2% glutaraldehyde, and then stained with 1 mg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) in the usual manner. Stained embryos were made transparent using ScaleA2 containing 4 M urea, 0.1% Triton X-100, and 10% glycerol (Hama et al., 2011) .
Histological analysis
Histological analyses were performed according to standard procedures. E10.5 embryos were fixed with 4% paraformaldehyde and embedded in O.C.T. compound (Sakura). Frozen sections (8-10 µm thick) were deposited on a Superfrost Plus slides (VWR-Menzel) and stained with hematoxylin-eosin or processed for immunohistochemistry as will be described later.
Immunohistochemistry
Frozen sections were washed in phosphate-buffered saline (PBS) to remove the O.C.T. compound. After antigen was reactivated by boiling the samples in sodium citrate buffer (pH 6.0), sections were blocked in TNB buffer (PerkinElmer) containing 10% donkey serum at room temperature for 1 hour, and then incubated with the primary antibody at 4°C overnight. Primary antibodies against the following proteins were used: nestin (1:250; R&D Systems), Tuj1 (1:500; Covance), N-cadherin (1:250; R&D systems), phospho-histone H3 (1:250; Cell Signaling), and cleaved caspase-3 (1:250; Cell Signaling). Signal was detected with Alexa Fluor 488 conjugated donkey anti-mouse IgG or Alexa Fluor 555 conjugated donkey anti-rabbit IgG (1:500; Molecular Probes).
4.7.
Western blotting
Quantitative RT-PCR analysis
Total RNA was isolated from whole embryos (E8.5 or E10.5) using the Nucleospin RNA ll Kit (Macherey-Nagel). A cDNA template was synthesized from 100 to 500 ng total RNA using the ReverTra Ace qPCR RT Master Mix with gDNA Remover (TOYOBO). Quantitative RT-PCR was performed using THUN-DERBIRD SYBR qPCR Mix (TOYOBO) and analyzed by a Light Cycler 480 System (Roche). Fold differences in gene expression were calculated using the relative standard curve method. The primer sequences are listed in Table 3 .
Statistical analysis
Results are expressed as means ± SE. All comparisons in this study were made using the two-tailed paired Student t-test. *p < 0.05, **p < 0.01. Fbxl11  F  5′-GCCAAGGCACTTGAAAGAAA-3′  R  5′-AGCAGCCTCGAACACTCATT-3′  Fbxl10  F  5′-GTTTCACTGACTTCCACATTGACTTT-3′  R 5′-GCAGGGTTGGAGGGATCAG-3′ Ezh2 F 5′-ACTGCTGGCACCGTCTGATG-3′ R 5′-TCCTGAGAAATAATCTCCCCACAG-3′ Ring1B F 5′-AGACTTCAGGCAATGCCACT-3′ R 5′-GGAGCCATTTAAAACGGTGA-3′ p15 Ink4b F 5′-AGATCCCAACGCCCTGAAC-3′ R 5′-TCGTGCACAGGTCTGGTAAG-3′ p16 Ink4a F 5′-GTACCCCGATTCAGGTGATG-3′ R 5′-AGGACCCCACTACCTTCTCC-3′ p18 Ink4c F 5′-CGTCAACGCTCAAAATGGAT-3′ R 5′-TGACAGCAAAACCAGTTCCA-3′ p19 Ink4d F 5′-GCAGGTCATGATGTTTGGAA-3′ R 5′-TAGTACCGGAGGCATCTTGG-3′ p19 Arf F 5′-GCTCTGGCTTTCGTGAACATG-3′ R 5′-TCGAATCTGCACCGTAGTTGAG-3′ p21 Cip1 F 5′-TTGCACTCTGGTGTCTGAGC-3′ R 5′-TCTGCGCTTGGAGTGATAGA-3′ p27 Kip1 F 5′-GGGTCTCAGGCAAACTCTGA-3′ R 5′-TCTGTTGGCCCTTTTGTTTT-3′ p57 F 5′-GGAGCAGGACGAGAATCAAG-3′ R 5′-GTTCTCCTGCGCAGTTCTCT-3′ p53 F 5′-CTCTCCCCCGCAAAAGAAAAA-3′ R 5′-CGGAACATCTCGAAGCGTTTA-3′ Gapdh F 5′-ATGAATACGGCTACAGCAACAGG-3′ R 5′-CTCTTGCTCAGTGTCCTTGCTG-3′
